MAZZONI, CAMILLA
 Distribuzione geografica
Continente #
AS - Asia 41
NA - Nord America 38
EU - Europa 20
AF - Africa 2
Totale 101
Nazione #
US - Stati Uniti d'America 38
SG - Singapore 19
CN - Cina 13
IT - Italia 9
IN - India 7
FI - Finlandia 4
CZ - Repubblica Ceca 3
CI - Costa d'Avorio 2
DE - Germania 2
ID - Indonesia 2
IE - Irlanda 2
Totale 101
Città #
Singapore 19
Santa Clara 13
Boardman 7
Bologna 7
Hyderabad 6
Brno 3
Lappeenranta 3
Abidjan 2
Bari 2
Dublin 2
Guangzhou 2
Jakarta 2
Munich 2
Chandler 1
Chengdu 1
Dongyang 1
Helsinki 1
Langfang 1
Los Angeles 1
Mountain View 1
Mumbai 1
Phoenix 1
Wuhan 1
Xi'an 1
Totale 81
Nome #
Longer-term response to SARS-CoV-2 vaccine in MPN patients: Role of ruxolitinib and disease severity 25
Sustained response off therapy after fostamatinib: A chronic refractory ITP case report 19
Predictors of Response to Hydroxyurea and Switch to Ruxolitinib in HU-Resistant Polycythaemia VERA Patients: A Real-World PV-NET Study 19
Ruxolitinib in cytopenic myelofibrosis: Response, toxicity, drug discontinuation, and outcome 18
Immune Thrombocytopenia Onset and Relapse During the COVID-19 Pandemic. A Monocenter Study 15
Determinants of Covid19 disease and of survival after Covid19 in MPN patients treated with ruxolitinib 14
Efficacy and Safety of Frontline Single‐Agent Rituximab in Extranodal Marginal Zone Lymphoma 9
Totale 119
Categoria #
all - tutte 711
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 711


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/20238 0 0 0 0 4 0 0 1 3 0 0 0
2023/202436 2 3 1 0 2 0 0 5 1 6 9 7
2024/202575 8 8 15 11 25 8 0 0 0 0 0 0
Totale 119